Eric Pauwels
2021 - PTC Therapeutics
In 2021, Eric Pauwels earned a total compensation of $4.3M as Chief Business Officer at PTC Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $297,700 |
|---|---|
| Option Awards | $2,790,550 |
| Salary | $502,250 |
| Stock Awards | $678,198 |
| Other | $10,518 |
| Total | $4,279,216 |
Pauwels received $2.8M in option awards, accounting for 65% of the total pay in 2021.
Pauwels also received $297.7K in non-equity incentive plan, $502.3K in salary, $678.2K in stock awards and $10.5K in other compensation.
Rankings
In 2021, Eric Pauwels' compensation ranked 3,107th out of 12,405 executives tracked by ExecPay. In other words, Pauwels earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,107 out of 12,405 | 75th |
Division Manufacturing | 1,246 out of 5,494 | 77th |
Major group Chemicals And Allied Products | 503 out of 2,369 | 79th |
Industry group Drugs | 445 out of 2,090 | 79th |
Industry Pharmaceutical Preparations | 305 out of 1,537 | 80th |
Source: SEC filing on April 28, 2022.
Pauwels' colleagues
We found four more compensation records of executives who worked with Eric Pauwels at PTC Therapeutics in 2021.